★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN Learn more →

Log In | Become a Member | Sponsor | ⌕ Search

Compliance & EnforcementNews

Archive

News

10,690 articles from the Compliance & Enforcement Brief.

Advertisement

Materiality Concerns For CARES Act Enforcement Cases

DOJ Revises its Corporate Compliance Guidance (Part I of II)

FCPA Defendant Seeks SCOTUS Review

Public Disclosure Bar Jurisdictional, Regardless of Other Pleading Deficiencies; United States Court of Appeals for the Second Circuit, No. 18-3376, U.S. ex rel. Don Hanks v. Florida Cancer Specialists, et al.

Experience With Specific Medical Procedures Not Only Avenue to Determining Expertise of Relator’s Witnesses; United States District Court for the District of Utah, No. 2:16-CV-304 TS, U.S. ex rel. Gerald Polukoff M.D. v. St. Mark’s Hospital, et al.

For-Profit Virtual Conferences Shouldn’t Sell Access to FCPA Enforcement Officials

How to Limit Litigation Risk from the Increased Use of Chat Programs During the COVID-19 Pandemic

Senate Judiciary Committee Hearing Highlights COVID-19 Enforcement Trends and Priorities

DOJ Updates Corporate Compliance Guidance

Materiality & the Public Disclosure Bar: Fending Off Qui Tam Attacks

Key Takeaways from DOJ’s Revised Corporate Compliance Program Guidance

Compliance Week Offers Roadmap for Auditors Managing COVID-19 Challenges

The Five Most Important Issues in DOJ’s Revised Compliance Program Guidance

U.K. Serious Fraud Office Looks for Ways to Improve Handling of Cases

Ericsson Begins Monitorship Under U.S. Deferred Prosecution Agreement

Res Judicata Cannot Bar Qui Tam Complaint When Government Not a Party to Prior Lawsuit; United States Court of Appeals for the Ninth Circuit No. 18-56532, U.S. ex rel. Hrayr Shahinian M.D. v. Kimberly-Clark Corporation

Fifth Circuit Holds Statistics Don’t (Show a) Lie

At Large: Is This the Most Important Change in the DOJ’s New Guidance?

U.S. DOJ Announced Further Updates of Its Guidance for Evaluation of Corporate Compliance Program

Alaska Neurology Center LLC and Its Owner to Pay $2 Million to Settle False Claims Act Allegations Regarding Fraudulent Medical Billing